From: Vitamin D receptor gene polymorphism and hepatocellular carcinoma in chronic hepatitis C patients
 | Group A Control (n = 34) | Group B HCC (n = 34) | Group C chronic hepatitis (n = 34) | P value |
---|---|---|---|---|
Age | 49.3 ± 6.5 | 53.8 ± 8.3a | 50.9 ± 6.9 | 0.06* |
Gender (M/F) | 16/18 | 23/11 | 17/17 | 0.182 |
BMI (kg/ m2) | 23.09 ± 0.45 | 23.19 ± 0.47 | 23.16 ± 0.49 | 0.668 |
Total bilirubin (mg/dl) | 0.85 ± 0.17 | 2.32 ± 1.33a | 1.87 ± 1.14b | 0.005* |
Direct bilirubin (mg/dl) | 0.39 ± 0.11 | 0.81 ± 0.58a | 0.97 ± 0.67b | 0.032* |
ALT (IU/L) | 25 ± 3.55 | 97.79 ± 25.32a | 91.41 ± 60.27b | < 0.001** |
AST (IU/L) | 22.67 ± 4.28 | 77.71 ± 21.53a | 93.94 ± 85.15b | < 0.001** |
Albumin (g/dl) | 4.22 ± 0.44 | 2.82 ± 0.71a | 3.06 ± 0.47b | < 0.001** |
ALP (IU/L) | 64.35 ± 11.39 | 108.97 ± 37.7a | 112.38 ± 57.31b | < 0.001** |
AFP (ng/mL) | 6.45 ± 1.63 | 3599.09 ± 4450.75a | 26.13 ± 23.87c | < 0.001** |
Creatinine (mg/dL) | 0.87 ± 0.12 | 1.04 ± 0.27a | 0.94 ± 0.19 | 0.004* |
Urea (mg/dL). | 33.85 ± 3.74 | 31.59 ± 3.89a | 33.15 ± 2.87 | 0.029* |
Hemoglobin (g/dL) | 12.71 ± 0.76 | 12.28 ± 1.61a | 12.03 ± 1.61b | 0.125 |
Platelets count (× 103 mm3) | 222 ± 49.14 | 134.97 ± 7.13a | 130.77 ± 73.72b | < 0.001** |
INR | 1.02 ± 0.04 | 1.38 ± 0.39a | 1.49 ± 0.43b | < 0.001** |
PT (s) | 12.27 ± 0.46 | 16.68 ± 4.91a | 17.89 ± 5.17b | < 0.001** |